ConductScience.org, home

Paper34952829

Epigenetic basis and targeting of cancer metastasis.

Banerjee R and 4 others. Trends Cancer, 2022. Cited by 38 papers, by iCite.

Cite this record

ConductScience Library. Epigenetic basis and targeting of cancer metastasis. Papers, record 34952829. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34952829

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Epigenetic basis and targeting of cancer metastasis.
PubMed
Journal
Trends Cancer
PubMed
Year
2022
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
38
iCite
Relative citation ratio, by iCite
2.38
iCite
Revised in PubMed
2022-04-01
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Banerjee RRakesh
2Smith JJim
3Eccles MRMichael R
4Weeks RJRobert J
5Chatterjee AAniruddha

Source PubMed

Download CSV of authors

Topics4

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
EpigenomicsMajor topic
NeoplasmsMajor topic
Epigenesis, Genetic
Humans

Cited by31

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.

PMIDTitleJournalYearIn PapersSource
42966745KDM1A promotes colorectal cancer progression by regulating NRP2 and VEGFA-related signaling.Oncogene2026https://conductscience.org/library/papers/42966745PubMed
42373805DNA methylation-mediated silencing of STAT5A drives breast cancer metastasis via dual regulation of EMT and immunosuppressive microenvironment.Oncogene2026https://conductscience.org/library/papers/42373805PubMed
41971440The symbiotic axis between the acidic tumor microenvironment and cancer stem cells: a driver of malignancy and therapeutic resistance.Front Oncol2026https://conductscience.org/library/papers/41971440PubMed
41898551Epigenetic Deregulation of Transposable Elements Links Developmental Processes and Tumorigenesis.Int J Mol Sci2026https://conductscience.org/library/papers/41898551PubMed
41869309ADAMTS9-AS2 acts as an epigenetic brake to constrain DNMT3B-mediated CADM2 silencing in esophageal squamous cell carcinoma metastasis.Front Immunol2026https://conductscience.org/library/papers/41869309PubMed
41083431The noncanonical function of liver-type phosphofructokinase potentiates the efficacy of HDAC inhibitors in cancer.Signal Transduct Target Ther2025https://conductscience.org/library/papers/41083431PubMed
40691387Epigenetic dysregulation in cancer: mechanisms, diagnostic biomarkers and therapeutic strategies.Med Oncol2025https://conductscience.org/library/papers/40691387PubMed
40675967Targeting epigenetic regulators as a promising avenue to overcome cancer therapy resistance.Signal Transduct Target Ther2025https://conductscience.org/library/papers/40675967PubMed
40473600SWI/SNF ATPase silenced HLF potentiates lung metastasis in solid cancers.Nat Commun2025https://conductscience.org/library/papers/40473600PubMed
40287757YEATS2: a novel cancer epigenetic reader and potential therapeutic target.Cancer Cell Int2025https://conductscience.org/library/papers/40287757PubMed
39904827EZH2-Mediated PHF10 Suppression Amplifies HMGB1/NF-κB Axis That Confers Chemotherapy Resistance in Cholangiocarcinoma.J Cell Mol Med2025https://conductscience.org/library/papers/39904827PubMed
39725831Pan-cancer and multiomics: advanced strategies for diagnosis, prognosis, and therapy in the complex genetic and molecular universe of cancer.Clin Transl Oncol2025https://conductscience.org/library/papers/39725831PubMed
39581913Vaping and tumor metastasis: current insights and progress.Cancer Metastasis Rev2024https://conductscience.org/library/papers/39581913PubMed
39391208From microscopes to molecules: The evolution of prostate cancer diagnostics.Cytojournal2024https://conductscience.org/library/papers/39391208PubMed
39095874Cancer, metastasis, and the epigenome.Mol Cancer2024https://conductscience.org/library/papers/39095874PubMed
38800486The effect of epigenetic aging on neurodegenerative diseases: a Mendelian randomization study.Front Endocrinol (Lausanne)2024https://conductscience.org/library/papers/38800486PubMed
38473261Targeted DNA Methylation Editing Using an All-in-One System Establishes Paradoxical Activation of EBF3.Cancers (Basel)2024https://conductscience.org/library/papers/38473261PubMed
38357830Integrated Multiomics Reveals Silencing of has_circ_0006646 Promotes TRIM21-Mediated NCL Ubiquitination to Inhibit Hepatocellular Carcinoma Metastasis.Adv Sci (Weinh)2024https://conductscience.org/library/papers/38357830PubMed
38255946Exploring Potential Epigenetic Biomarkers for Colorectal Cancer Metastasis.Int J Mol Sci2024https://conductscience.org/library/papers/38255946PubMed
37985455Application of deep learning in cancer epigenetics through DNA methylation analysis.Brief Bioinform2023https://conductscience.org/library/papers/37985455PubMed

See all 31 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34952829

GET https://conductscience.org/api/papers/v1/34952829/cited_by?page=2